Press Release Archives - Page 2 of 2

MOMA Therapeutics Announces $150 Million Series B Financing

Proceeds to fund the advancement of multiple precision oncology programs toward the clinic Financing led by Goldman Sachs Asset Management and includes multiple leading healthcare funds CAMBRIDGE, Mass., May 10,…

MOMA Therapeutics Appoints Hans Bitter, Ph.D., as Senior Vice President and Head, Data Science

Company Expands Leadership Team with Appointment of Nazareth Martinez Shedden as Vice President, Strategic Finance CAMBRIDGE, Mass., October 5, 2021 – MOMA Therapeutics, a biopharmaceutical company discovering the next generation…

Fierce Biotech names MOMA Therapeutics as one of its “Fierce 15” Biotech Companies of 2021

Fierce Biotech names MOMA Therapeutics as one of its “Fierce 15” Biotech Companies of 2021 Cambridge, MA – September 27, 2021 – MOMA Therapeutics today announced that Fierce Biotech has…

MOMA Therapeutics Appoints Semi Trotto as Chief People and Experience Officer

CAMBRIDGE, Mass., September 8, 2021 – MOMA Therapeutics, a biopharmaceutical company discovering the next generation of precision medicines by targeting molecular machines that underlie human disease, today announced that Semi…

MOMA Therapeutics Appoints Peter Hammerman, M.D., Ph.D., as Chief Scientific Officer

CAMBRIDGE, Mass., May 3, 2021 – MOMA Therapeutics, a biopharmaceutical company discovering the next generation of precision medicines by targeting molecular machines that underlie human disease, today announced that Peter…

MOMA Therapeutics Appoints Asit Parikh, M.D., Ph.D. as President and Chief Executive Officer

CAMBRIDGE, Mass., February 1, 2021 – MOMA Therapeutics, a biopharmaceutical company discovering the next generation of precision medicines by targeting molecular machines that underlie human disease, today announced that Asit…